Your search returned 3 results.

Results
	1.	Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial. [electronic resource] by Kruis, W Kiudelis, G Rácz, I Gorelov, I A Pokrotnieks, J Horynski, M Batovsky, M Kykal, J Boehm, S Greinwald, R Mueller, R Producer: 20090210 In: Gut vol. 58 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis. [electronic resource] by Kruis, W Jonaitis, L Pokrotnieks, J Mikhailova, T L Horynski, M Bátovský, M Lozynsky, Y S Zakharash, Y Rácz, I Kull, K Vcev, A Faszczyk, M Dilger, K Greinwald, R Mueller, R Producer: 20110603 In: Alimentary pharmacology & therapeutics vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Randomised non-inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild-to-moderate ulcerative colitis. [electronic resource] by D'Haens, G R Sandborn, W J Zou, G Stitt, L W Rutgeerts, P J Gilgen, D Jairath, V Hindryckx, P Shackelton, L M Vandervoort, M K Parker, C E Muller, C Pai, R K Levchenko, O Marakhouski, Y Horynski, M Mikhailova, E Kharchenko, N Pimanov, S Feagan, B G Producer: 20171211 In: Alimentary pharmacology & therapeutics vol. 46 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)